SKI Market

Indian Indices

Nifty

24,500.90 -211.15
(-0.85%)

Sensex

80,080.57 -705.97
( -0.87%)

Bank Nifty

53,820.35 -630.10
( -1.16%)

Nifty IT

35,488.80 -574.40
( -1.59%)

Global Indices

Nasdaq

45,588.04 148.96
(0.33%)

Dow Jones

6,502.95 16.01
(0.25%)

Hang Seng

42,793.22 272.95
(0.64%)

Nikkei 225

9,255.50 -10.30
(-0.11%)

Forex

USD-INR

87.65 0.14
(0.16%)

EUR-INR

102.03 -0.15
(-0.14%)

GBP-INR

118.08 0.03
(0.03%)

JPY-INR

0.59 0.00
(0.15%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Nectar Lifescience Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

532649

INE023H01027

42.6340837

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

NECLIFE

337.29

EPS(TTM)

Face Value()

Div & Yield %

Back

Alka Securities reports standalone net profit of Rs 0.01 crore in the December 2024 quarter

Feb 12,2025

Net profit of Alka Securities remain constant at Rs 0.01 crore in the quarter ended December 2024 and also during the previous quarter ended December 2023. Sales remain constant at Rs 0.02 crore in the quarter ended December 2024 and also during the previous quarter ended December 2023.

Particulars	Quarter Ended
	Dec. 2024	Dec. 2023	% Var.
Sales	0.02	0.02	0
OPM %	-200.00	-300.00	-
PBDT	0.03	0.01	200
PBT	0.01	0.01	0
NP	0.01	0.01	0

24,500.90 -211.15 (-0.85%)

80,080.57 -705.97 ( -0.87%)

53,820.35 -630.10 ( -1.16%)

35,488.80 -574.40 ( -1.59%)

45,588.04 148.96 (0.33%)

6,502.95 16.01 (0.25%)

42,793.22 272.95 (0.64%)

9,255.50 -10.30 (-0.11%)

87.65 0.14 (0.16%)

102.03 -0.15 (-0.14%)

118.08 0.03 (0.03%)

0.59 0.00 (0.15%)